Search

everythinglearnresearchcommunity

for

Search:↓

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Complete COVID-19 vaccination reduces the risk of long COVID.

No link found between Coxsackie viruses and pemphigus.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

The cat was put to sleep due to recurring infections.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

A liver transplant patient with APECED had a rare VZV recurrence and pneumonia, treated successfully, but later died from other infections.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

The document is a detailed medical reference on skin and genetic disorders.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

A woman experienced total hair loss after an HPV vaccine, but treatment helped regrow her hair.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Some patients treated with peginterferon and ribavirin for chronic hepatitis C had mild to moderate skin reactions, but treatment did not need to be stopped.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

A vitamin D receptor mutation causes rickets and affects immune responses.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.